Georgios Manousakis

An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study

Timothy M. Miller, Alan Pestronk, William David et al. · The Lancet Neurology · 2013 · 603 citations · Full text

Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study

James F. Howard, Saskia Bresch, Angela Genge et al. · The Lancet Neurology · 2023 · 213 citations

Medicine, Surgery, Clinical Trials +1

Safety and efficacy of givinostat in boys with Duchenne muscular dystrophy (EPIDYS): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Eugenio Mercuri, Juan J. Vílchez, Odile Boespflug‐Tanguy et al. · The Lancet Neurology · 2024 · 100 citations

Duchenne Muscular Dystrophy, Clinical Trials, Pharmacotherapy +2

Multifocal radiculoneuropathy during ipilimumab treatment of melanoma

Georgios Manousakis, James P. Koch, R. Brian Sommerville et al. · Muscle & Nerve · 2013 · 76 citations · Full text

A first presentation of multiple sclerosis with concurrent COVID-19 infection

Lisa E. Moore, Malik Ghannam, Georgios Manousakis · eNeurologicalSci · 2020 · 49 citations · Full text

Virus Epidemiology, Viral Diagnostics, Neurological Disorder +16